These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 3336237
1. Neoadjuvant chemotherapy for locally advanced transitional cell carcinoma of the bladder: do local findings suggest a potential for salvage of the bladder? Zincke H, Sen SE, Hahn RG, Keating JP. Mayo Clin Proc; 1988 Jan; 63(1):16-22. PubMed ID: 3336237 [Abstract] [Full Text] [Related]
2. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder. Sternberg CN, Arena MG, Calabresi F, De Carli P, Platania A, Zeuli M, Giannarelli D, Cancrini A, Pansadoro V. Cancer; 1993 Sep 15; 72(6):1975-82. PubMed ID: 8364877 [Abstract] [Full Text] [Related]
11. [Polychemotherapy in advanced bladder cancer. Practicality and clinical results]. Klän R, Knispel H, Huland H. Urologe A; 1992 Jul 15; 31(4):247-50. PubMed ID: 1514213 [Abstract] [Full Text] [Related]
12. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers]. Takenaka A, Gotoh A, Hara I, Gohji K, Ogawa T, Arakawa S, Matsumoto O, Kamidono S, Hamami G, Itani A. Gan To Kagaku Ryoho; 1990 Sep 15; 17(9):1909-15. PubMed ID: 2393308 [Abstract] [Full Text] [Related]
18. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer. Maarouf AM, Khalil S, Salem EA, ElAdl M, Nawar N, Zaiton F. BJU Int; 2011 May 15; 107(10):1605-10. PubMed ID: 20825396 [Abstract] [Full Text] [Related]